鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/02/15 | 2,820 | 2,900 | 2,819 | 2,882 | +89 | +3.2% | 97,800 |
2017/02/14 | 2,817 | 2,820 | 2,780 | 2,793 | -9 | -0.3% | 82,200 |
2017/02/13 | 2,800 | 2,810 | 2,798 | 2,802 | +20 | +0.7% | 46,200 |
2017/02/10 | 2,709 | 2,788 | 2,709 | 2,782 | +107 | +4% | 75,100 |
2017/02/09 | 2,670 | 2,684 | 2,658 | 2,675 | -2 | -0.1% | 13,800 |
2017/02/08 | 2,659 | 2,678 | 2,623 | 2,677 | -9 | -0.3% | 61,100 |
2017/02/07 | 2,695 | 2,698 | 2,677 | 2,686 | -17 | -0.6% | 22,600 |
2017/02/06 | 2,710 | 2,718 | 2,678 | 2,703 | -2 | -0.1% | 55,700 |
2017/02/03 | 2,658 | 2,715 | 2,658 | 2,705 | +197 | +7.9% | 90,600 |
2017/02/02 | 2,519 | 2,550 | 2,496 | 2,508 | -4 | -0.2% | 24,300 |
2017/02/01 | 2,479 | 2,525 | 2,479 | 2,512 | +13 | +0.5% | 24,000 |
2017/01/31 | 2,520 | 2,525 | 2,483 | 2,499 | -31 | -1.2% | 17,000 |
2017/01/30 | 2,510 | 2,530 | 2,478 | 2,530 | +9 | +0.4% | 21,700 |
2017/01/27 | 2,529 | 2,539 | 2,513 | 2,521 | +3 | +0.1% | 14,700 |
2017/01/26 | 2,512 | 2,528 | 2,481 | 2,518 | +38 | +1.5% | 23,100 |
2017/01/25 | 2,550 | 2,560 | 2,463 | 2,480 | -55 | -2.2% | 43,500 |
2017/01/24 | 2,529 | 2,562 | 2,522 | 2,535 | +33 | +1.3% | 65,100 |
2017/01/23 | 2,560 | 2,560 | 2,502 | 2,502 | -58 | -2.3% | 19,100 |
2017/01/20 | 2,522 | 2,569 | 2,504 | 2,560 | +31 | +1.2% | 35,500 |
2017/01/19 | 2,514 | 2,536 | 2,507 | 2,529 | +15 | +0.6% | 17,100 |
2017/01/18 | 2,589 | 2,589 | 2,508 | 2,514 | -69 | -2.7% | 28,300 |
2017/01/17 | 2,581 | 2,596 | 2,563 | 2,583 | +2 | +0.1% | 31,700 |
2017/01/16 | 2,546 | 2,587 | 2,536 | 2,581 | +18 | +0.7% | 21,600 |
2017/01/13 | 2,541 | 2,579 | 2,540 | 2,563 | -12 | -0.5% | 43,400 |
2017/01/12 | 2,640 | 2,640 | 2,567 | 2,575 | -102 | -3.8% | 68,800 |
2017/01/11 | 2,587 | 2,691 | 2,561 | 2,677 | +120 | +4.7% | 77,400 |
2017/01/10 | 2,594 | 2,597 | 2,556 | 2,557 | -10 | -0.4% | 85,100 |
2017/01/06 | 2,552 | 2,593 | 2,544 | 2,567 | -1 | ±0% | 52,800 |
2017/01/05 | 2,560 | 2,585 | 2,560 | 2,568 | -8 | -0.3% | 35,800 |
2017/01/04 | 2,564 | 2,600 | 2,564 | 2,576 | -9 | -0.3% | 52,100 |
2016/12/30 | 2,580 | 2,587 | 2,538 | 2,585 | +5 | +0.2% | 20,200 |
2016/12/29 | 2,597 | 2,606 | 2,561 | 2,580 | -17 | -0.7% | 24,100 |
2016/12/28 | 2,570 | 2,611 | 2,535 | 2,597 | ±0 | ±0% | 18,500 |
2016/12/27 | 2,599 | 2,628 | 2,561 | 2,597 | +6 | +0.2% | 28,100 |
2016/12/26 | 2,650 | 2,650 | 2,582 | 2,591 | -19 | -0.7% | 62,700 |
2016/12/22 | 2,553 | 2,611 | 2,549 | 2,610 | +58 | +2.3% | 34,000 |
2016/12/21 | 2,555 | 2,600 | 2,528 | 2,552 | -3 | -0.1% | 89,900 |
2016/12/20 | 2,548 | 2,585 | 2,544 | 2,555 | +5 | +0.2% | 51,200 |
2016/12/19 | 2,553 | 2,577 | 2,541 | 2,550 | -13 | -0.5% | 31,900 |
2016/12/16 | 2,585 | 2,588 | 2,556 | 2,563 | -13 | -0.5% | 28,100 |
2016/12/15 | 2,563 | 2,580 | 2,544 | 2,576 | +10 | +0.4% | 36,600 |
2016/12/14 | 2,552 | 2,580 | 2,536 | 2,566 | +14 | +0.5% | 40,500 |
2016/12/13 | 2,505 | 2,575 | 2,505 | 2,552 | +9 | +0.4% | 60,200 |
2016/12/12 | 2,486 | 2,558 | 2,486 | 2,543 | +9 | +0.4% | 39,000 |
2016/12/09 | 2,522 | 2,542 | 2,496 | 2,534 | +12 | +0.5% | 51,700 |
2016/12/08 | 2,573 | 2,573 | 2,501 | 2,522 | -41 | -1.6% | 28,600 |
2016/12/07 | 2,474 | 2,568 | 2,474 | 2,563 | +95 | +3.8% | 33,900 |
2016/12/06 | 2,475 | 2,495 | 2,455 | 2,468 | +9 | +0.4% | 53,400 |
2016/12/05 | 2,432 | 2,463 | 2,432 | 2,459 | +16 | +0.7% | 26,100 |
2016/12/02 | 2,441 | 2,449 | 2,407 | 2,443 | -11 | -0.4% | 15,500 |
1901~
1950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 479,500円 | +12.0% | +28.1% | 2.50% | 26.43倍 | 1.12倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
東和薬品 | 284,100円 | +15.0% | -7.3% | 2.11% | 9.32倍 | 0.88倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 282,700円 | +52.1% | +23.3% | 0.00% | 20.07倍 | 3.85倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 333,500円 | +3.0% | +27.5% | 2.40% | 21.12倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 226,500円 | +13.6% | +29.2% | 2.03% | 11.75倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム